Lithium API Manufacturers

Looking for Lithium API 7439-93-2?

Description:

Here you will find a list of producers, manufacturers and distributors of Lithium. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Lithium 

Synonyms:

Li(+) , Lithium cation , Lithium ion , Lithium , ion , Lithii  

Cas Number:

7439-93-2 

DrugBank number:

DB01356 

Unique Ingredient Identifier:

9FN79X2M3F

Lithium is a type of Lithium salts

Lithium salts are a vital subcategory of active pharmaceutical ingredients (APIs) widely used in the pharmaceutical industry. These compounds are derived from lithium, a naturally occurring element with therapeutic properties. Lithium salts exhibit unique chemical and physiological characteristics that make them valuable in the treatment of various mental health disorders, particularly bipolar disorder.

The most commonly used lithium salt is lithium carbonate, which is typically administered orally as a mood stabilizer. Lithium citrate and lithium sulfate are also utilized, although to a lesser extent. These salts undergo rigorous quality control measures to ensure purity, potency, and safety.

Lithium salts work by modulating neurotransmitter levels in the brain, including serotonin and norepinephrine, thereby balancing mood fluctuations. Their precise mechanism of action is still not fully understood but is believed to involve altering the intracellular signaling pathways of neurons.

Pharmaceutical manufacturers prioritize the production of high-quality lithium salts that comply with strict regulatory standards. Advanced manufacturing processes, such as crystallization, precipitation, and drying techniques, are employed to achieve consistent particle size distribution, uniformity, and optimal bioavailability.

Despite their therapeutic efficacy, lithium salts may cause side effects such as gastrointestinal disturbances, tremors, and kidney-related issues. Hence, close monitoring of patients undergoing lithium therapy is essential to prevent adverse events.

In conclusion, lithium salts are a crucial subcategory of pharmaceutical APIs used in the management of bipolar disorder. The development and manufacturing of high-quality lithium salts play a pivotal role in ensuring patient well-being and optimizing treatment outcomes.

Lithium (Lithium salts), classified under Central Nervous System Agents

Central Nervous System (CNS) Agents are a crucial category of pharmaceutical Active Pharmaceutical Ingredients (APIs) that specifically target the central nervous system. The CNS encompasses the brain and spinal cord, playing a vital role in regulating and controlling various bodily functions, including cognition, movement, emotions, and sensory perception. These agents are designed to interact with specific receptors, enzymes, or ion channels within the CNS to modulate neural activity and restore normal functioning.

CNS agents comprise a diverse range of pharmaceutical APIs, including analgesics, anesthetics, antipsychotics, sedatives, hypnotics, anti-epileptics, and antidepressants. Each subcategory addresses distinct neurological disorders and conditions. For instance, analgesics alleviate pain by targeting receptors in the brain and spinal cord, while antipsychotics are employed to manage psychosis symptoms in mental illnesses such as schizophrenia.

The development of CNS agents involves rigorous research, molecular modeling, and extensive clinical trials to ensure safety, efficacy, and specific target engagement. Pharmaceutical companies invest significant resources in identifying novel drug targets, synthesizing new compounds, and optimizing their pharmacological properties. These agents undergo rigorous regulatory evaluations and must adhere to stringent quality standards and guidelines.

Given the prevalence of CNS disorders globally, the market demand for effective CNS agents is substantial. The development of innovative CNS APIs not only improves patient outcomes but also provides valuable commercial opportunities for pharmaceutical companies. Continued advancements in CNS agent research and development hold the promise of groundbreaking therapies that can improve the quality of life for individuals affected by neurological conditions.

• Critical Minerals Refining from United States, product country of origin United States
• Duchefa Farma B.V. from Netherlands, product country of origin Germany
• Euticals from Italy, product country of origin Unknown
• Albemarle from United States, product country of origin United States
• Lek Pharma from Slovenia, product country of origin India
• Sun Pharma from India, product country of origin India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.